Trek Diagnostic Systems opens new U.K. manufacturing and research plant

CLEVELAND, Ohio — Trek Diagnostic Systems, which makes microbiology test kits used by diagnostic labs, has opened a new manufacturing and research facility in the United Kingdom.

Trek, which was acquired in 2006 by Boston-based Magellan Biosciences, opened the new plant to “meet increasing global demand” for its Sensitire product line of “susceptibility plates,” according to a statement from the company.

The plates are used to determine the appropriate drug and dosage levels required to treat bacterial and yeast infections.

“We outgrew our previous facility thanks to increasing demand for our expanding line of susceptibility products, which provide our customers with the cost-effective and reliable microbiology results they need to make more-informed treatment decisions,” said James Whelan, president of Magellan Clinical Diagnostics.